Create a narrative

Exagen Community

NasdaqGM:XGN Community

1 Narratives written by author
0 Comments on narratives written by author
4 Fair Values set on narratives written by author

Create a narrative

AN

AnalystConsensusTarget

Consensus Narrative from 4 Analysts

Biomarker Launch And AVISE CTD Expansion Will Drive Future Success

Key Takeaways New biomarkers and biopharma partnerships are expected to drive revenue growth and enhance diagnostic capabilities, accelerating earnings growth. Improvements in ASP and sales efficiencies are expanding gross margins, with strategic plans set to boost test volumes and revenue growth.

US$6.75

FV

10.8% undervalued

15.13%

Revenue growth p.a.

0

0

3

2 days ago